Description
Diaglizid MR (gliclazide) Tablets with Prolonged Release 30 mg. №30
Composition
Active ingredient: Gliclazide 30 mg.
Other ingredients: [List other ingredients here]
Mechanism of Action
Gliclazide, the active ingredient in Diaglizid MR tablets, is a sulfonylurea class of antidiabetic agents. It stimulates insulin release from the pancreas, reducing blood sugar levels in patients with type 2 diabetes.
Pharmacological Properties
Diaglizid MR tablets exhibit hypoglycemic effects by increasing insulin secretion from pancreatic beta cells. The prolonged-release formulation ensures sustained drug levels, contributing to better glycemic control over time.
Indications for Use
Diaglizid MR tablets are indicated for the treatment of type 2 diabetes mellitus when lifestyle interventions are insufficient in managing blood glucose levels effectively.
Contraindications
Avoid Diaglizid MR tablets if you have a known allergy to gliclazide or any components in the formulation. These tablets are not suitable for individuals with type 1 diabetes or diabetic ketoacidosis.
Side Effects
Common side effects of Diaglizid MR tablets may include hypoglycemia, gastrointestinal disturbances, and hypersensitivity reactions. Consult your healthcare provider if you experience any adverse effects.
Usage Instructions
For adults, the typical dosage is 30 mg once daily with breakfast. Dosage adjustments may be necessary based on individual blood sugar levels. Swallow the tablet whole with water; do not crush or chew.
Benefits Compared to Analogues
Diaglizid MR tablets offer a convenient once-daily dosing schedule and a lower risk of hypoglycemia due to their extended-release formulation. Clinical trials have demonstrated the efficacy and safety of gliclazide in managing type 2 diabetes.
Suitable Patient Groups
Diaglizid MR tablets are suitable for adult patients with type 2 diabetes who require oral antidiabetic therapy. Dosage adjustments may be necessary for elderly individuals or those with renal impairment.
Storage and Shelf Life
Store Diaglizid MR tablets in a cool, dry place away from direct sunlight. Check the packaging for the expiration date and do not use expired medication.
Packaging Description
Diaglizid MR tablets are available in packs of 30 tablets with each tablet containing 30 mg of gliclazide. The packaging is designed to maintain the stability and integrity of the tablets.
Clinical Evidence and Proven Effectiveness
Clinical studies have shown that gliclazide effectively improves glycemic control and reduces the risk of diabetic complications in patients with type 2 diabetes. Research published in the Journal of Diabetes Investigation supports the efficacy of gliclazide in managing blood sugar levels.
